INTERNATIONAL PATENT: DOMPE' FARMACEUTICI S.P.A. FILES APPLICATION FOR "BDNF FOR THE TREATMENT OF RHODOPSIN-MEDIATED RETINITIS PIGMENTOSA"

GENEVA, Sept. 21 -- DOMPE' FARMACEUTICI S.P.A. (Via San Martino, 1220122 Milano) filed a patent application (PCT/EP2025/056892) for "BDNF FOR THE TREATMENT OF RHODOPSIN-MEDIATED RETINITIS PIGMENTOSA" on Mar 13, 2025. With publication no. WO/2025/191075, the details related to the patent application was published on Sep 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ARAMINI, Andrea (C/0 DOMPE' FARMACEUTICI SPAVia Campo di Pile, snc67100 L'Aquila), BRANDOLINI, Laura (c/o Dompe farmaceutici SpaVia Campo di Pile, snc67100 L'Aquila), NOVELLI, Rubina (Dompe Farmaceutici S.p.A.Via Santa Lucia ...